<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03482830</url>
  </required_header>
  <id_info>
    <org_study_id>PHASE</org_study_id>
    <nct_id>NCT03482830</nct_id>
  </id_info>
  <brief_title>Perioperative Metabolic and Hormonal Aspects in Major Emergency Surgery</brief_title>
  <acronym>PHASE</acronym>
  <official_title>Perioperative Metabolic and Hormonal Aspects in Major Emergency Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergency laparotomies, which most often is performed due to high risk disease (bowel
      obstruction, ischemia, perforation, etc.), make up 11 % of surgical procedures in emergency
      surgical departments, however, give rise to 80 % of all postoperative complications. The
      30-day mortality rates in relation to these emergent procedures have been reported between
      14-30 %, with even higher numbers for frail and older patients. The specific reasons for
      these outcomes are not yet known, however, a combination of preexisting comorbidities, acute
      illness, sepsis, and the surgical stress response that arise during- and after the surgical
      procedure due to the activation of the immunological and humoral system, is most likely to
      blame. The complex endocrinological response and consequences of this response to emergency
      surgery are sparsely reported in the literature.

      The aim of this PHASE project is to evaluate and describe the temporal endocrine, endothelial
      and immunological changes after major emergency abdominal surgery, and to associate these
      changes with clinical postoperative outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of immunological biomarkers</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of:
plasma inflammatory interleukines incl. IL-1-alfa, IL-1beta, IL-6, IL-10
plasma TNF-alfa
plasma TGF-beta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with stress induced hyperglycemia</measure>
    <time_frame>Postoperative day 5</time_frame>
    <description>Assessment of:
Blood glucose, plasma c-peptide, HbA1C
plasma Glucagon-like peptide 1 (GLP-1)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of plasma thyroid hormones</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of:
Thyropin-releasing hormone (TRH)
Thyroid-stimulating hormone (TSH)
Thyroid hormones (fT3, fT4, rT3)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of the central endocrine stress response</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma corticotropin releasing hormone (CRH)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of sE-selectin</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma sE-selectine
sE-selectin
syndecan-1
thrombomodulin
sVE-cadherin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of the endothelial function</measure>
    <time_frame>Change from postoperative day 1 at postoperative day 5</time_frame>
    <description>Assessed with the non-invasive EndoPAT and expressed as the reactive hyperemia index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of the periferal endocrine stress response</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma adrenocorticotropic hormone (ACTH)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of cortisol</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma cortisol (free and bound)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of neuropeptides</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma neuropeptides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of syndecan-1</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma syndecan-1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of thrombomodulin</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma thrombomodulin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of sVE-cadherin</measure>
    <time_frame>Change from preoperative levels at postoperative day 5</time_frame>
    <description>Assessment of plasma sVE-cadherin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with major adverse cardiovascular events</measure>
    <time_frame>365 days after surgery</time_frame>
    <description>Defined as:
Cardiovascular death
Myocardial injury within postoperative day 4 (definition: peak plasma cardiac troponin-I ≥ 45ng/L (99th percentile URL, 10% CV at 40ng/L))
Acute coronary syndrome (unstable angina pectoris, NSTEMI, STEMI)
Congestive heart failure
Stroke
Nonfatal cardiac arrest
New clinically important cardiac arrhythmia
Coronary revascularization procedure (PCI or CABG)
Sudden unexpected death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with postoperative non-cardiovascular complications</measure>
    <time_frame>365 days after surgery</time_frame>
    <description>Defined as:
Non-cardiovascular death with other defined reason for death
Sepsis (sepsis - severe sepsis - septic shock)
Pneumonia
Respiratory failure
Surgical complications (Clavien-Dindo stage 3)
Any non-cardiovascular life-threatening complication (Clavien-Dindo stage 4)
Readmission due to a non-cardiovascular complication</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Surgery--Complications</condition>
  <condition>Acute Illness</condition>
  <condition>Gastrointestinal Disease</condition>
  <condition>Stress</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Major emergency gastrointestinal surgery</intervention_name>
    <description>Open, laparoscopic, or laparoscopically-assisted procedures
Procedures involving the stomach, small or large bowel, or rectum for conditions such as perforation, ischaemia, abdominal abscess, bleeding or obstruction</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients ≥ 18 years old undergoing acute major gastrointestinal surgery within 72 hours of
        their admission to the Department of Surgery or an acute reoperation.

        Major gastrointestinal surgery are defined as procedures involving the stomach, small or
        large bowel, or rectum for conditions such as perforation, ischaemia, abdominal abscess,
        bleeding or obstruction.

        Patients will be consecutively screened for inclusion.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Surgery within 72 hours of an acute admission to the Department of Surgery or an acute
             reoperation.

          -  Major gastrointestinal surgery on the gastrointestinal tract (see intervention
             definition)

        Exclusion Criteria:

          -  Not capable of giving informed consent after oral and written information

          -  Previously included in the trial

          -  Elective laparoscopy

          -  Diagnostic laparotomy/laparoscopy where no subsequent procedure is performed (NB, if
             no procedure is performed because of inoperable pathology, then include)

          -  Appendectomy +/- drainage or Cholecystectomy +/- drainage of localized collection
             unless the procedure is incidental to a non-elective procedure on the GI tract

          -  Non-elective hernia repair without bowel resection.

          -  Minor abdominal wound dehiscence unless this causes bowel complications requiring
             resection

          -  Ruptured ectopic pregnancy, or pelvic abscesses due to pelvic inflammatory disease

          -  Laparotomy/laparoscopy for pathology caused by blunt or penetrating trauma, esophageal
             pathology, pathology of the spleen, renal tract, kidneys, liver, gall bladder and
             biliary tree, pancreas or urinary tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jakob Burcharth, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Ekeloef, MD, PhD</last_name>
    <phone>004547323012</phone>
    <email>savb@regionsjaelland.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jakob Burcharth, MD, PhD</last_name>
    <email>jbur@regionsjaelland.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Surgery, Zealand University Hospital</name>
      <address>
        <city>Køge</city>
        <zip>2300</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Ekeloef</last_name>
      <phone>+45 47323012</phone>
      <email>savb@regionsjaelland.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.regionsjaelland.dk/sundhed/geo/koegesygehus/afdelinger/kirurgisk-afdeling/CSS/Sider/default.aspx</url>
    <description>Center for Surgical Science</description>
  </link>
  <reference>
    <citation>Huddart S, Peden CJ, Swart M, McCormick B, Dickinson M, Mohammed MA, Quiney N; ELPQuiC Collaborator Group; ELPQuiC Collaborator Group. Use of a pathway quality improvement care bundle to reduce mortality after emergency laparotomy. Br J Surg. 2015 Jan;102(1):57-66. doi: 10.1002/bjs.9658. Epub 2014 Nov 10.</citation>
    <PMID>25384994</PMID>
  </reference>
  <reference>
    <citation>Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, Koenderman L, Kubes P, Lilford RJ. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet. 2014 Oct 18;384(9952):1455-65. doi: 10.1016/S0140-6736(14)60687-5. Epub 2014 Oct 17. Review.</citation>
    <PMID>25390327</PMID>
  </reference>
  <reference>
    <citation>Preiser JC, Ichai C, Orban JC, Groeneveld AB. Metabolic response to the stress of critical illness. Br J Anaesth. 2014 Dec;113(6):945-54. doi: 10.1093/bja/aeu187. Epub 2014 Jun 26. Review.</citation>
    <PMID>24970271</PMID>
  </reference>
  <reference>
    <citation>Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care Med. 2013 Jun;41(6):e93-4. doi: 10.1097/CCM.0b013e318283d124.</citation>
    <PMID>23685597</PMID>
  </reference>
  <reference>
    <citation>Hassan-Smith Z, Cooper MS. Overview of the endocrine response to critical illness: how to measure it and when to treat. Best Pract Res Clin Endocrinol Metab. 2011 Oct;25(5):705-17. doi: 10.1016/j.beem.2011.04.002. Review.</citation>
    <PMID>21925072</PMID>
  </reference>
  <reference>
    <citation>Gibbison B, Angelini GD, Lightman SL. Dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery. Br J Anaesth. 2013 Sep;111(3):347-60. doi: 10.1093/bja/aet077. Epub 2013 May 9. Review.</citation>
    <PMID>23661405</PMID>
  </reference>
  <reference>
    <citation>Münzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med. 2008;40(3):180-96. doi: 10.1080/07853890701854702. Review.</citation>
    <PMID>18382884</PMID>
  </reference>
  <reference>
    <citation>Ekeloef S, Larsen MH, Schou-Pedersen AM, Lykkesfeldt J, Rosenberg J, Gögenür I. Endothelial dysfunction in the early postoperative period after major colon cancer surgery. Br J Anaesth. 2017 Feb;118(2):200-206. doi: 10.1093/bja/aew410.</citation>
    <PMID>28100523</PMID>
  </reference>
  <reference>
    <citation>McIlroy DR, Chan MT, Wallace SK, Symons JA, Koo EG, Chu LC, Myles PS. Automated preoperative assessment of endothelial dysfunction and risk stratification for perioperative myocardial injury in patients undergoing non-cardiac surgery. Br J Anaesth. 2014 Jan;112(1):47-56. doi: 10.1093/bja/aet354. Epub 2013 Oct 29.</citation>
    <PMID>24172055</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inflammation</keyword>
  <keyword>Insulin-glucose homeostasis</keyword>
  <keyword>Hypothalamic-pituitary-adrenal axis</keyword>
  <keyword>Endothelial function and damage</keyword>
  <keyword>Thyroid hormones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

